Levy JC - Search Results

1

An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study.

Wallace TM, Levy JC, Matthews DR. Wallace TM, et al. Among authors: levy jc. Diabet Med. 2004 Jun;21(6):568-76. doi: 10.1111/j.1464-5491.2004.01218.x. Diabet Med. 2004. PMID: 15154941 Clinical Trial.

2

Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2.

Hill NR, Levy JC, Matthews DR. Hill NR, et al. Among authors: levy jc. Diabetes Care. 2013 Aug;36(8):2324-30. doi: 10.2337/dc12-0607. Epub 2013 Apr 5. Diabetes Care. 2013. PMID: 23564921 Free PMC article.

3

Use and abuse of HOMA modeling.

Wallace TM, Levy JC, Matthews DR. Wallace TM, et al. Among authors: levy jc. Diabetes Care. 2004 Jun;27(6):1487-95. doi: 10.2337/diacare.27.6.1487. Diabetes Care. 2004. PMID: 15161807 Review.

4

Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.

Levy JC, Rudenski A, Burnett M, Knight R, Matthews DR, Turner RC. Levy JC, et al. Diabetologia. 1991 Jul;34(7):488-99. doi: 10.1007/BF00403285. Diabetologia. 1991. PMID: 1916054

5

Application of structural model of glucose-insulin relations to assess beta-cell function and insulin sensitivity.

Turner RC, Rudenski AS, Matthews DR, Levy JC, O'Rahilly SP, Hosker JP. Turner RC, et al. Among authors: levy jc. Horm Metab Res Suppl. 1990;24:66-71. Horm Metab Res Suppl. 1990. PMID: 2272629 Review.

6

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).

Adler AI, Levy JC, Matthews DR, Stratton IM, Hines G, Holman RR. Adler AI, et al. Among authors: levy jc. Diabet Med. 2005 Mar;22(3):306-11. doi: 10.1111/j.1464-5491.2004.01418.x. Diabet Med. 2005. PMID: 15717879

7

A method for assessing quality of control from glucose profiles.

Hill NR, Hindmarsh PC, Stevens RJ, Stratton IM, Levy JC, Matthews DR. Hill NR, et al. Among authors: levy jc. Diabet Med. 2007 Jul;24(7):753-8. doi: 10.1111/j.1464-5491.2007.02119.x. Epub 2007 Apr 19. Diabet Med. 2007. PMID: 17459094

8

Three-year efficacy of complex insulin regimens in type 2 diabetes.

Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK; 4-T Study Group. Holman RR, et al. Among authors: levy jc. N Engl J Med. 2009 Oct 29;361(18):1736-47. doi: 10.1056/NEJMoa0905479. Epub 2009 Oct 22. N Engl J Med. 2009. PMID: 19850703 Free article. Clinical Trial.

9

Impending type 2 diabetes.

Matthews DR, Levy JC. Matthews DR, et al. Among authors: levy jc. Lancet. 2009 Jun 27;373(9682):2178-9. doi: 10.1016/S0140-6736(09)60865-5. Epub 2009 Jun 8. Lancet. 2009. PMID: 19515411 No abstract available.

10

Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes.

Rudenski AS, Matthews DR, Levy JC, Turner RC. Rudenski AS, et al. Among authors: levy jc. Metabolism. 1991 Sep;40(9):908-17. doi: 10.1016/0026-0495(91)90065-5. Metabolism. 1991. PMID: 1895955

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

265 results

Search Page